SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-014719
Filing Date
2024-02-12
Accepted
2024-02-12 16:48:07
Documents
1
Group Members
SAMSARA BIOCAPITAL GP, LLCSRINIVAS AKKARAJU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm245884d1_sc13da.htm SC 13D/A 68663
  Complete submission text file 0001104659-24-014719.txt   70320
Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

IRS No.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94000 | Film No.: 24620792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)